Photo from wikipedia
Striatal foot deformity can shorten the stance phase of gait and impair the ability to stand and walk. Botulinum neurotoxin type A (BoNT A) is a treatment option. However, no… Click to show full abstract
Striatal foot deformity can shorten the stance phase of gait and impair the ability to stand and walk. Botulinum neurotoxin type A (BoNT A) is a treatment option. However, no previous study has included clinical balance testing in the evaluation of treatment effects. The aim of this study was to evaluate gait and balance in patients with striatal foot deformities and Parkinson's disease (PD) before and after treatment with BoNT A injections.
Keywords:
treatment;
gait;
parkinson disease;
striatal foot;
balance
Journal Title: Movement Disorders Clinical Practice
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Movement Disorders Clinical Practice
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!